IκB Kinase α Phosphorylation of TRAF4 Downregulates Innate: Immune Signaling

Molecular and Cellular Biology

Volumn 32, Issue 13, 2012, Pages 2479-2489

  Marinis, Jill M ^a   Hutti, Jessica E ^b   Homer, Craig R ^e   Cobb, Brian A ^a   Cantley, Lewis C ^c,d   McDonald, Christine ^e   Abbott, Derek W ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; I KAPPA B KINASE ALPHA; SERINE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 4;

ARTICLE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; HUMAN; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; CROHN DISEASE; DNA PRIMERS; DOWN-REGULATION; HCT116 CELLS; HEK293 CELLS; HUMANS; I-KAPPA B KINASE; IMMUNITY, INNATE; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NF-KAPPA B; NOD2 SIGNALING ADAPTOR PROTEIN; PEPTIDE LIBRARY; PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SERINE; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; TNF RECEPTOR-ASSOCIATED FACTOR 4;

EID: 84863994274     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00106-12     Document Type: Article

References (53)

1. Abbott DW, Wilkins A, Asara JM, Cantley LC. 2004. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr. Biol. 14:2217-2227.
2. Abbott DW, et al. 2007. Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains. Mol. Cell. Biol. 27: 6012-6025.
3. Casanova JL, Abel L. 2009. Revisiting Crohn's disease as a primary immunodeficiency of macrophages. J. Exp. Med. 206:1839 -1843.
4. Chung JY, Lu M, Yin Q, Lin SC, Wu H. 2007. Molecular basis for the unique specificity of TRAF6. Adv. Exp. Med. Biol. 597:122-130.
5. Chung JY, Park YC, Ye H, Wu H. 2002. All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J. Cell Sci. 115:679-688.
6. Coll RC, O'Neill LA. 2010. New insights into the regulation of signalling by toll-like receptors and nod-like receptors. J. Innate Immun. 2:406- 421.
7. Dephoure N, et al. 2008. A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 105:10762-10767.
8. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. 2006. Nod-like proteins in immunity, inflammation and disease. Nat. Immunol. 7:1250 -1257.
9. Ghosh S, Karin M. 2002. Missing pieces in the NF-κB puzzle. Cell 109(Suppl):S81-S96.
10. Hacker H, Karin M. 2006. Regulation and function of IKK and IKKrelated kinases. Sci. STKE 2006:re13. doi:10.1126/stke.3572006re13.
11. Hayden MS, Ghosh S. 2008. Shared principles in NF-κB signaling. Cell 132:344 -362.
12. Hisamatsu T, et al. 2003. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124:993- 1000.
13. Homer CR, Richmond AL, Rebert NA, Achkar JP, McDonald C. 2010. ATG16L1 and NOD2 interact in an autophagy-dependent, anti-bacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology 139:1630 -1641.
14. Hu MC, et al. 2004. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117:225-237.
15. Hugot JP, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599-603.
16. Hutchins AP, Robson P. 2009. Unraveling the human embryonic stem cell phosphoproteome. Cell Stem Cell 5:126 -128.
17. Hutti JE, et al. 2004. A rapid method for determining protein kinase phosphorylation specificity. Nat. Methods 1:27-29.
18. Hutti JE, et al. 2009. Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKK∑ promotes cell transformation. Mol. Cell 34:461- 472.
19. Hutti JE, et al. 2007. IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-κB pathway. Mol. Cell. Biol. 27:7451-7461.
20. Inohara N, et al. 2000. An induced proximity model for NF-κB activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275:27823- 27831.
21. Inohara N, et al. 2003. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278:5509 -5512.
22. Kalkan T, Iwasaki Y, Park CY, Thomsen GH. 2009. Tumor necrosis factor-receptor-associated factor-4 is a positive regulator of transforming growth factor-beta signaling that affects neural crest formation. Mol. Biol. Cell 20:3436 -3450.
23. Kanazawa N, et al. 2005. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 105:1195-1197.
24. Kedinger V, et al. 2005. Spatial and temporal distribution of the traf4 genes during zebrafish development. Gene Expr. Patterns 5:545-552.
25. Kedinger V, Rio MC. 2007. TRAF4, the unique family member. Adv. Exp. Med. Biol. 597:60 -71.
26. Kim YG, et al. 2008. The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity 28:246 -257.
27. Kobayashi K, et al. 2002. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416:194- 199.
28. Lawrence T, Bebien M, Liu GY, Nizet V, Karin M. 2005. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 434:1138 -1143.
29. Li Q, et al. 2005. Enhanced NF-κB activation and cellular function in macrophages lacking IκB kinase 1 (IKK1). Proc. Natl. Acad. Sci. U. S. A. 102:12425-12430.
30. Li S, et al. 2010. Ubiquitin ligase Smurf1 targets TRAF family proteins for ubiquitination and degradation. Mol. Cell. Biochem. 338:11-17.
31. Li X, Yang Y, Ashwell JD. 2002. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416:345-347.
32. Li ZW, et al. 1999. The IKKβsubunit of IκB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J. Exp. Med. 189:1839 -1845.
33. Luo JL, et al. 2007. Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 446:690-694.
34. Marinis JM, Homer CR, McDonald C, Abbott DW. 2011. A novel motif in the Crohn's disease susceptibility protein, NOD2, allows TRAF4 to down-regulate innate immune responses. J. Biol. Chem. 286:1938 -1950.
35. Oehlers SH, et al. 2011. The inflammatory bowel disease (IBD) susceptibility genes NOD1 and NOD2 have conserved anti-bacterial roles in zebrafish. Dis. Model. Mech. 4:832- 841.
36. Ogura Y, et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603- 606.
37. Ogura Y, et al. 2001. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J. Biol. Chem. 276:4812- 4818.
38. Olsen JV, et al. 2010. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci. Signal. 3:ra3. doi:10.1126/scisignal.2000475.
39. Park YC, Burkitt V, Villa AR, Tong L, Wu H. 1999. Structural basis for self-association and receptor recognition of human TRAF2. Nature 398: 533-538.
40. Razani B, et al. 2010. Negative feedback in noncanonical NF-κB signaling modulates NIK stability through IKKα-mediated phosphorylation. Sci. Signal. 3:ra41. doi:10.1126/scisignal.2000778.
41. Reiley W, Zhang M, Wu X, Granger E, Sun SC. 2005. Regulation of the deubiquitinating enzyme CYLD by IκB kinase gamma-dependent phosphorylation. Mol. Cell. Biol. 25:3886 -3895.
42. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. 1999. IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274:30353-30356.
43. Shembade N, Pujari R, Harhaj NS, Abbott DW, Harhaj EW. 2011. The kinase IKKα inhibits activation of the transcription factor NF-κB by phosphorylating the regulatory molecule TAX1BP1. Nat. Immunol. 12:834- 843.
44. Smahi A, et al. 2002. The NF-κB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immunedeficiency syndromes. Hum. Mol. Genet. 11:2371-2375.
45. Strober W, Watanabe T. 2011. NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease. Mucosal Immunol. 4:484-495.
46. Takeda K, et al. 1999. Limb and skin abnormalities in mice lacking IKKα. Science 284:313-316.
47. Takeshita F, et al. 2005. TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF. Eur. J. Immunol. 35:2477-2485.
48. Turk BE, Hutti JE, Cantley LC. 2006. Determining protein kinase substrate specificity by parallel solution-phase assay of large numbers of peptide substrates. Nat. Protoc. 1:375-379.
49. Watanabe T, et al. 2006. Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigenspecific colitis. Immunity 25:473- 485.
50. Wegener E, et al. 2006. Essential role for IκB kinase beta in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation. Mol. Cell 23: 13-23.
51. Yamamoto-Furusho JK, Barnich N, Hisamatsu T, Podolsky DK. 2010. MDP-NOD2 stimulation induces HNP-1 secretion, which contributes to NOD2 antibacterial function. Inflamm. Bowel Dis. 16:736 -742.
52. Ye H, et al. 2002. Distinct molecular mechanism for initiating TRAF6 signalling. Nature 418:443- 447.
53. Ye H, Park YC, Kreishman M, Kieff E, Wu H. 1999. The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol. Cell 4:321-330.